Neurokinin 1 receptor
Eprazinone specifically displaces binding to the NK1R. Although Eprazinone displays a rather weak inhibition of [ 125 I]BH-SP binding to NK1R, at a concentration of 25 μM, and an antagonistic effect of about 30%, NK1R blockade could contribute to its mucolytic activity.